Z Squared Inc. reported its financial results for the second quarter of 2026, marking a significant transition following its merger with Z Squared, Inc. on April 24, 2026. The company generated total revenue of $1.58 million for the three months ended June 30, 2026, primarily from its cryptocurrency mining operations, which included $1.39 million from Dogecoin and $190,475 from Litecoin mining. This revenue reflects the company's entry into the crypto asset mining sector, as it had no revenue during the same period in the previous year.

The company's financial performance also revealed a gross loss of approximately $1.77 million, with total costs of revenue amounting to $3.35 million, which included $1.16 million in depreciation. The total cost of operations reached $12.03 million, driven largely by professional services expenses of $4.20 million and stock-based compensation of $7.03 million. Consequently, Z Squared reported a net loss of $13.79 million for the quarter, translating to a loss per share of $0.28, compared to no prior period figures due to the lack of operations in 2025.

Strategically, Z Squared has shifted its focus from biopharmaceutical activities to cryptocurrency mining and is exploring expansion into artificial intelligence (AI) and high-density compute infrastructure. The company operates its mining facilities across six locations in North Carolina, South Carolina, and Iowa, utilizing approximately 9,800 ASIC mining machines contributed by its controlling shareholder, BSG Series CM LLC. The company is also pursuing potential acquisitions to support its expansion strategy, including a recent agreement to acquire Paradox Data, LLC, which is expected to enhance its capabilities in AI and data center development.

As of June 30, 2026, Z Squared reported cash and cash equivalents of $15.49 million, a significant increase from $1,402 at the end of 2025. This increase was primarily due to $15.42 million raised through a Standby Equity Purchase Agreement. The company has indicated that its existing cash is sufficient to fund operations for at least the next twelve months, although it anticipates needing additional capital to fully execute its expansion strategy into AI and high-density compute infrastructure. The company’s management has acknowledged the inherent risks associated with this strategy, including the volatility of cryptocurrency prices and the challenges of entering new markets.

About Z Squared Inc.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company focused on developing innovative cell and antibody therapies for cancer and viral infections. Its core activities include advancing natural killer (NK) cell platforms, CAR T-cell technologies, and diagnostic tools. The company collaborates with academic and industry partners to develop targeted treatments, aiming to improve efficacy and safety in oncology and infectious disease markets.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov